Category: Fundamentals Sulfonylureas increase insulin secretion by binding to specific beta-cell receptors. This class of drug is contraindicated in patients with a known allergy to sulfa agents. Patients with renal failure may be predisposed to hypoglycemia.
No comments :
Post a Comment